Dublin, April 02, 2026 (GLOBE NEWSWIRE) — The “Throat Cancer Market Report 2026” has been added to ResearchAndMarkets.com’s offering.
The throat cancer market has exhibited significant growth in recent years, expanding from $2.45 billion in 2025 to an anticipated $2.67 billion in 2026, with a compound annual growth rate (CAGR) of 8.9%. This recent expansion is largely due to rising tobacco and alcohol consumption, the increasing prevalence of HPV infections, advancements in cancer diagnostic capabilities, and expanded oncology treatment infrastructure. Additionally, rising awareness of throat cancer symptoms greatly contributes to this market’s growth.
Projected trends indicate that the throat cancer market will continue its growth trajectory, reaching $3.71 billion by 2030, with a CAGR of 8.6%. Driving forces behind this forecast include significant investments in targeted cancer therapies, an increased demand for minimally invasive treatments, and broader adoption of personalized medicine and AI-driven diagnostics. Precision oncology approaches, advanced diagnostic imaging, and early cancer detection are becoming increasingly prominent, enhancing early-stage intervention and treatment efficacy.
An increase in the smoking population, influenced by factors such as higher stress levels, is expected to further propel market growth. Throat cancer’s linkage to smoking underscores the need for heightened public awareness and preventive initiatives. For instance, a 2024 study by the European Respiratory Society highlighted a significant rise in smoking rates among young people, who reported increasing from 22.5% in 2022 to 40.1% in 2024, further driving demand for throat cancer treatment solutions.
Technological advancements play a crucial role in the market’s growth, with key companies focusing on innovations in robotic and imaging-assisted surgeries. Notable developments include real-time cellular-level imaging, which enhances surgical precision. In January 2025, Mauna Kea Technologies introduced a new application that integrates its Cellvizio confocal laser endomicroscopy into transoral robotic surgery, providing real-time cellular imaging to delineate tumor boundaries and improve surgical outcomes.
Collaborative efforts are also expected to bolster the market. In January 2024, Inovio Pharmaceuticals Inc. partnered with Coherus BioSciences to advance DNA-based cancer immunotherapies. This collaboration focuses on enhancing HPV-associated cancer treatments, promising improved patient outcomes through innovative approaches.
Leading players in the throat cancer market include Pfizer Inc, Roche Holding AG, Merck & Co Inc, AbbVie Inc, Sanofi SA, and others. North America was the largest region in this market in 2025, with significant markets also in Asia-Pacific, Western Europe, and beyond. However, tariffs are impacting costs related to imported medical systems, influencing treatment expenses and procurement timelines.
Reasons to Purchase:
- Gain global insights with the most comprehensive report covering 16 regions.
- Evaluate the impact of macro factors including geopolitical tensions, trade policies, inflation, and regulatory changes.
- Formulate regional and country-specific strategies using local data.
- Identify lucrative growth segments for investment opportunities.
- Leverage forecast data to stay ahead of competitors by understanding market drivers and trends.
- Understand customer dynamics through end-user analysis.
- Benchmark performance against top competitors by market share, innovation, and brand strength.
- Determine market potential with a thorough evaluation of total addressable market (TAM) and market attractiveness score (MAS).
- Support presentations with reliable data and in-depth analysis, enhanced by regular data updates and Excel dashboards.
Markets Covered:
- By Type: Pharyngeal Cancer; Laryngeal Cancer
- By Treatments: Surgery; Radiation Therapy; Targeted Therapy; Chemotherapy; and more
- By End-User: Hospitals; Cancer Research Institutes; Multispecialty Clinics; Ambulatory Surgical Centers
Subsegments:
- Pharyngeal Cancer: Oropharyngeal, Nasopharyngeal, Hypopharyngeal
- Laryngeal Cancer: Glottic, Supraglottic, Subglottic
Companies Mentioned: Pfizer Inc, Roche Holding AG, Merck & Co Inc, AbbVie Inc, and others.
Regions and Countries: Asia-Pacific, South East Asia, Western Europe, North America, and more.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $2.67 Billion |
| Forecasted Market Value (USD) by 2030 | $3.71 Billion |
| Compound Annual Growth Rate | 8.6% |
| Regions Covered | Global |
The companies featured in this Throat Cancer market report include:
- Pfizer Inc
- Roche Holding AG
- Merck And Co Inc
- AbbVie Inc
- Sanofi SA
- Bristol Myers Squibb
- AstraZeneca plc
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Amgen Inc
- Astellas Pharma Inc
- Dr Reddy’s Laboratories
- Biocon Ltd
- Coherus BioSciences Inc
- Inovio Pharmaceuticals Inc
- Boston Biomedical Inc
- Shanghai Sunway Biotech Co Ltd
- Eisai Co Ltd
For more information about this report visit https://www.researchandmarkets.com/r/yg0hp5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
